Fig. 3From: Exposure–response analyses of cabozantinib in patients with metastatic renal cell cancerScatterplots of the cabozantinib Cmin levels at starting dose and at best tolerated dose for patients with and without a dose reduction. Abbreviations: DR, dose reduction. Whiskers show median and interquartile range (IQR). Shaded area represents the IQR of exposure reached at best tolerated dose of 40 mgBack to article page